Experience with tocilizumab in patients with neuromyelitis optica spectrum disorders
Introduction: Neuromyelitis optica spectrum disorders (NMOSD) are immune-mediated inflammatory disorders of the central nervous system involving astrocytes, B lymphocytes, anti-aquaporin 4, and such inflammatory mediators as interleukin-6. Several immunosuppressants are used in their treatment. Toci...
Main Authors: | E. Carreón Guarnizo, R. Hernández Clares, T. Castillo Triviño, V. Meca Lallana, V. Arocas Casañ, F. Iniesta Martínez, J. Olascoaga Urtaza, J.E. Meca Lallana |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2022-04-01
|
Series: | Neurología (English Edition) |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580821000237 |
Similar Items
-
Mujer con diagnóstico de novo de espectro de neuromielitis óptica con anticuerpos para AQP4 positivo. Un Reporte de Caso
by: Neiby Johana Rivera Rojas, et al.
Published: (2021-08-01) -
Esclerosis múltiple en la población pediátrica
by: Gustavo A. Suárez Z., et al.
Published: (2007-07-01) -
Esclerosis múltiple en la población pediátrica
by: Gustavo A. Suárez Z., et al.
Published: (2007-07-01) -
Neuromielitis Óptica (Enfermedad de Devic)
by: Luis Aguirre-Padilla, et al.
Published: (2017-07-01) -
Evolución clínica en neuromielitis óptica comparando el manejo con azatioprina o rituximab
by: Paulina Sánchez Botero, et al.
Published: (2023-04-01)